Author

Kimberly K. Laubmeier

Observed names: K Laubmeier, K. K. Laubmeier, K. Laubmeier, K.K. Laubmeier, Kimberly Laubmeier, Laubmeier, Kimberly

Institution: Sumitomo Dainippon Pharma (United States)

Observed institutions: Marquette University, Rosalind Franklin University of Medicine and Science, Otsuka (United States), Bristol-Myers Squibb (United States), Sunovion (United States), Sumitomo Dainippon Pharma (United States), Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)

ORCID: 0000-0002-7523-7067

Observed ORCID: 0000-0002-7523-7067

OpenAlex ID: A5014814860

The role of spirituality in the psychological adjustment to cancer: A test of the transactional model of stress and coping

2004 · Kimberly K. Laubmeier, Sandra G. Zakowski, et al. · International Journal of Behavioral Medicine · 221

Social barriers to emotional expression and their relations to distress in male and female cancer patients

2003 · Sandra G. Zakowski, Casey Harris, et al. · British Journal of Health Psychology · 132

Gender and stress: Differential psychophysiological reactivity to stress reexposure in the laboratory

2008 · Brian J. Schmaus, Kimberly K. Laubmeier, et al. · International Journal of Psychophysiology · 97

The role of objectiveversusperceived life threat in the psychological adjustment to cancer

2004 · Kimberly K. Laubmeier, Sandra G. Zakowski · Psychology and Health · 45

Real-world predictors of relapse in patients with schizophrenia and schizoaffective disorder in a large health system

2024 · Anne Rivelli, Veronica Fitzpatrick, et al. · Schizophrenia · 42

PDF

Psychological Adjustment Following Diagnosis and Treatment of Cancer: An Examination of the Moderating Role of Positive and Negative Emotional Expressivity

2006 · Phillip J. Quartana, Kimberly K. Laubmeier, et al. · Journal of Behavioral Medicine · 35

Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid.

2014 · Seth A Seabury, Dana P Goldman, et al. · PubMed · 32

Diagnoses Associated With Use of Atypical Antipsychotics in a Commercial Health Plan: A Claims Database Analysis

2013 · Leslie Citrome, Iftekhar Kalsekar, et al. · Clinical Therapeutics · 32

PDF

Chronic Administration of Propranolol Impairs Inhibitory Avoidance Retention in Mice

1999 · K.A. Nielson, D.A. Czech, et al. · Neurobiology of Learning and Memory · 24

Chronic Propranolol Induces Deficits in Retention but Not Acquisition Performance in the Water Maze in Mice

2000 · D.A. Czech, K.A. Nielson, et al. · Neurobiology of Learning and Memory · 21

Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy

2014 · J. Craig Nelson, Zia Rahman, et al. · CNS Spectrums · 19

PDF

Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy

2014 · D. E. Casey, K. K. Laubmeier, et al. · International Journal of Clinical Practice · 9

PDF

Efficacy of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Response Quartile Analysis and the Predictive Value of Week 2 Early Response

2012 · Daniel E. Casey, Kimberly K. Laubmeier, et al. · The Primary Care Companion For CNS Disorders · 7

Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data

2021 · Xiaoli Niu, Syvart Dennen, et al. · Current Therapeutic Research · 4

Beneficial Effects of Adjunctive Aripiprazole in Major Depressive Disorder Are Not Dependent on Antidepressant Therapy History: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Trials

2012 · David L. Dunner, Kimberly K. Laubmeier, et al. · The Primary Care Companion For CNS Disorders · 3

Impact of lurasidone on health-related quality of life in adults with bipolar depression: a post-hoc analysis

2022 · Carole Dembek, Qi Fan, et al. · Current Medical Research and Opinion · 2

Hospitalization risk among adults with bipolar I disorder treated with lurasidone versus other oral atypical antipsychotics: a retrospective analysis of Medicaid claims data

2021 · Xiaoli Niu, Phani Veeranki, et al. · Current Medical Research and Opinion · 2

PDF

Hospitalization Risk Among Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics: A Long-Term Data Analysis of Medicaid Claims Data

2021 · Xiaoli Niu, Phani Veeranki, et al. · CNS Spectrums · 1

PDF

Predictors of Relapse in Patients with Schizophrenia and Schizoaffective Disorders in Real-World Data from a Large Health System

2024 · Anne Rivelli, Veronica Fitzpatrick, et al. · CNS Spectrums

PDF

EE196 Healthcare Resource Use Among Patients Treated with Lurasidone or Cariprazine for Depressive Episodes Associated with Bipolar I Disorder

2022 · X Niu, D Goldschmidt, et al. · Value in Health

PDF

Use of a Second Generation Antipsychotic among Patients Diagnosed with Major Depressive Disorder in the United States: Prescribing Pattern and Influence of Physician Specialty

2012 · David A. Sclar, Linda M. Robison, et al. · Pharmaceutical Medicine

Effect of adjunctive aripiprazole in achieving various levels of response and on domains of functioning in MDD: A pooled analysis

2011 · R. Gismondi, Z. Cain, et al. · European Psychiatry

PDF

Works count: 23

Citation count: 728

H-index: 11

I10-index: 11